Blue Bell, PA, United States of America

M Brad Nolt

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2011-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: M Brad Nolt. Retrieved from https://idiyas.com/inventor/m-brad-nolt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 20.0

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Gilbertsville, PA (US) (2011)
  • Blue Bell, PA (US) (2011 - 2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: M Brad Nolt: Innovator in Potassium Channel Inhibitors

Introduction

M Brad Nolt is a distinguished inventor based in Blue Bell, PA (US), known for his significant contributions to the field of pharmacology. With a total of five patents to his name, he has made notable advancements in the development of potassium channel inhibitors, which are crucial in treating cardiac arrhythmias.

Latest Patents

Among his latest patents, M Brad Nolt has developed compounds that serve as potassium channel inhibitors. These compounds are designed to treat cardiac arrhythmias and similar conditions, showcasing his commitment to improving cardiac health through innovative solutions.

Career Highlights

M Brad Nolt is currently associated with Merck Sharp & Dohme Corporation, where he continues to push the boundaries of medical research and innovation. His work has not only contributed to the scientific community but has also had a profound impact on patient care.

Collaborations

Throughout his career, M Brad Nolt has collaborated with esteemed colleagues such as Scott E Wolkenberg and Mark T Bilodeau. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical solutions.

Conclusion

M Brad Nolt's contributions to the field of potassium channel inhibitors exemplify his dedication to innovation in medicine. His work continues to pave the way for advancements in the treatment of cardiac conditions, ultimately benefiting countless patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…